Corcept Therapeutics
The Associate supports Regulatory leadership in the development and execution of global nonclinical and clinical regulatory strategies, preparing for health authority interactions, and supporting regulatory submissions. This role involves collaborating with internal cross-functional teams and external partners to maintain up-to-date information on regulatory requirements and submissions. The position is based in Redwood City, California, and operates on a hybrid schedule requiring three days of on-site presence per week.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
1998
Corcept Therapeutics is a biopharmaceutical company that discovers and develops medicines that modulate the glucocorticoid receptor to treat disorders driven by excess cortisol. The company commercialized Korlym (mifepristone) for hyperglycemia secondary to endogenous Cushing’s syndrome and is advancing next‑generation, selective GR modulators (for example, relacorilant) through clinical development. Corcept combines translational science, clinical trials, and commercial capabilities to target endocrine and oncology indications where cortisol signaling contributes to disease. The company is headquartered in Menlo Park, California.
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT
8 hours ago
REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026
1 day ago
Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements
7 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Corcept Therapeutics.
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm – Company Announcement - FT.com
12 hours ago
Senior Manager, Global Regulatory Strategy, Neurosciences
Bristol Myers Squibb
Senior Manager, Global Regulatory Affairs
NewAmsterdam Pharma
Director of Quantitative Clinical Pharmacology
BioNTech
Director, US Regulatory Lead, GRS
Bristol Myers Squibb
Senior Regulatory Affairs Specialist
bostonscientific
Associate Scientist, Submissions Coordinator
AbbVie